OPTN ||| S:0 E:4 ||| NNP
/ ||| S:4 E:5 ||| NNP
SRTR  ||| S:5 E:10 ||| NNP
2011  ||| S:10 E:15 ||| CD
Annual  ||| S:15 E:22 ||| NNP
Data  ||| S:22 E:27 ||| NNP
Report ||| S:27 E:33 ||| NNP
:  ||| S:33 E:35 ||| :
liver  ||| S:35 E:41 ||| VBG
The  ||| S:41 E:45 ||| DT
current  ||| S:45 E:53 ||| JJ
liver  ||| S:53 E:59 ||| NN
allocation  ||| S:59 E:70 ||| NN
system ||| S:70 E:76 ||| NN
,  ||| S:76 E:78 ||| ,
introduced  ||| S:78 E:89 ||| VBN
in  ||| S:89 E:92 ||| IN
2002 ||| S:92 E:96 ||| CD
,  ||| S:96 E:98 ||| ,
decreased  ||| S:98 E:108 ||| VBD
the  ||| S:108 E:112 ||| DT
importance  ||| S:112 E:123 ||| NN
of  ||| S:123 E:126 ||| IN
waiting  ||| S:126 E:134 ||| VBG
time  ||| S:134 E:139 ||| NN
for  ||| S:139 E:143 ||| IN
allocation  ||| S:143 E:154 ||| NN
priorities ||| S:154 E:164 ||| NNS
;  ||| S:164 E:166 ||| :
the  ||| S:166 E:170 ||| DT
number  ||| S:170 E:177 ||| NN
of  ||| S:177 E:180 ||| IN
active  ||| S:180 E:187 ||| JJ
wait-listed  ||| S:187 E:199 ||| JJ
candidates  ||| S:199 E:210 ||| NNS
and  ||| S:210 E:214 ||| CC
median  ||| S:214 E:221 ||| JJ
waiting  ||| S:221 E:229 ||| VBG
times  ||| S:229 E:235 ||| NNS
were  ||| S:235 E:240 ||| VBD
immediately  ||| S:240 E:252 ||| RB
reduced ||| S:252 E:259 ||| VBN
.  ||| S:259 E:261 ||| .
However ||| S:261 E:268 ||| RB
,  ||| S:268 E:270 ||| ,
the  ||| S:270 E:274 ||| DT
total  ||| S:274 E:280 ||| JJ
number  ||| S:280 E:287 ||| NN
of  ||| S:287 E:290 ||| IN
adult  ||| S:290 E:296 ||| JJ
wait-listed  ||| S:296 E:308 ||| JJ
candidates  ||| S:308 E:319 ||| NNS
has  ||| S:319 E:323 ||| VBZ
increased  ||| S:323 E:333 ||| VBN
since  ||| S:333 E:339 ||| IN
2002 ||| S:339 E:343 ||| CD
,  ||| S:343 E:345 ||| ,
and  ||| S:345 E:349 ||| CC
median  ||| S:349 E:356 ||| JJ
waiting  ||| S:356 E:364 ||| VBG
time  ||| S:364 E:369 ||| NN
has  ||| S:369 E:373 ||| VBZ
increased  ||| S:373 E:383 ||| VBN
since  ||| S:383 E:389 ||| IN
2006 ||| S:389 E:393 ||| CD
.  ||| S:393 E:395 ||| .
Pretransplant  ||| S:395 E:409 ||| JJ
mortality  ||| S:409 E:419 ||| NN
rates  ||| S:419 E:425 ||| NNS
have  ||| S:425 E:430 ||| VBP
been  ||| S:430 E:435 ||| VBN
stable ||| S:435 E:441 ||| JJ
,  ||| S:441 E:443 ||| ,
but  ||| S:443 E:447 ||| CC
the  ||| S:447 E:451 ||| DT
number  ||| S:451 E:458 ||| NN
of  ||| S:458 E:461 ||| IN
candidates  ||| S:461 E:472 ||| NNS
withdrawn  ||| S:472 E:482 ||| VBN
from  ||| S:482 E:487 ||| IN
the  ||| S:487 E:491 ||| DT
list  ||| S:491 E:496 ||| NN
as  ||| S:496 E:499 ||| IN
being  ||| S:499 E:505 ||| VBG
too  ||| S:505 E:509 ||| RB
sick  ||| S:509 E:514 ||| JJ
to  ||| S:514 E:517 ||| TO
undergo  ||| S:517 E:525 ||| VB
transplant  ||| S:525 E:536 ||| NN
nearly  ||| S:536 E:543 ||| RB
doubled  ||| S:543 E:551 ||| VBN
between  ||| S:551 E:559 ||| IN
2009  ||| S:559 E:564 ||| CD
and  ||| S:564 E:568 ||| CC
2011 ||| S:568 E:572 ||| CD
.  ||| S:572 E:574 ||| .
Deceased  ||| S:574 E:583 ||| JJ
donation  ||| S:583 E:592 ||| NN
rates  ||| S:592 E:598 ||| NNS
have  ||| S:598 E:603 ||| VBP
remained  ||| S:603 E:612 ||| VBN
stable ||| S:612 E:618 ||| JJ
,  ||| S:618 E:620 ||| ,
with  ||| S:620 E:625 ||| IN
an  ||| S:625 E:628 ||| DT
increasing  ||| S:628 E:639 ||| JJ
proportion  ||| S:639 E:650 ||| NN
of  ||| S:650 E:653 ||| IN
expanded  ||| S:653 E:662 ||| JJ
criteria  ||| S:662 E:671 ||| NNS
donors ||| S:671 E:677 ||| NNS
.  ||| S:677 E:679 ||| .
Living  ||| S:679 E:686 ||| VBG
donation  ||| S:686 E:695 ||| NN
has  ||| S:695 E:699 ||| VBZ
decreased  ||| S:699 E:709 ||| VBN
over  ||| S:709 E:714 ||| IN
the  ||| S:714 E:718 ||| DT
past  ||| S:718 E:723 ||| JJ
10  ||| S:723 E:726 ||| CD
years ||| S:726 E:731 ||| NNS
.  ||| S:731 E:733 ||| .
Transplant  ||| S:733 E:744 ||| JJ
outcomes  ||| S:744 E:753 ||| NNS
remain  ||| S:753 E:760 ||| VBP
robust ||| S:760 E:766 ||| JJ
,  ||| S:766 E:768 ||| ,
with  ||| S:768 E:773 ||| IN
continuously  ||| S:773 E:786 ||| RB
improving  ||| S:786 E:796 ||| VBG
graft  ||| S:796 E:802 ||| JJ
survival  ||| S:802 E:811 ||| NN
rates  ||| S:811 E:817 ||| NNS
for  ||| S:817 E:821 ||| IN
deceased  ||| S:821 E:830 ||| JJ
donor ||| S:830 E:835 ||| NN
,  ||| S:835 E:837 ||| ,
living  ||| S:837 E:844 ||| VBG
donor ||| S:844 E:849 ||| NN
,  ||| S:849 E:851 ||| ,
and  ||| S:851 E:855 ||| CC
donation  ||| S:855 E:864 ||| NN
after  ||| S:864 E:870 ||| IN
circulatory  ||| S:870 E:882 ||| JJ
death  ||| S:882 E:888 ||| NN
livers ||| S:888 E:894 ||| NN
.  ||| S:894 E:896 ||| .
Numbers  ||| S:896 E:904 ||| NNS
of  ||| S:904 E:907 ||| IN
new  ||| S:907 E:911 ||| JJ
and  ||| S:911 E:915 ||| CC
prevalent  ||| S:915 E:925 ||| JJ
pediatric  ||| S:925 E:935 ||| JJ
candidates  ||| S:935 E:946 ||| NNS
on  ||| S:946 E:949 ||| IN
the  ||| S:949 E:953 ||| DT
waiting  ||| S:953 E:961 ||| VBG
list  ||| S:961 E:966 ||| NN
have  ||| S:966 E:971 ||| VBP
decreased ||| S:971 E:980 ||| VBN
.  ||| S:980 E:982 ||| .
Pediatric  ||| S:982 E:992 ||| JJ
pretransplant  ||| S:992 E:1006 ||| JJ
mortality  ||| S:1006 E:1016 ||| NN
has  ||| S:1016 E:1020 ||| VBZ
decreased ||| S:1020 E:1029 ||| VBN
,  ||| S:1029 E:1031 ||| ,
most  ||| S:1031 E:1036 ||| RBS
dramatically  ||| S:1036 E:1049 ||| RB
for  ||| S:1049 E:1053 ||| IN
candidates  ||| S:1053 E:1064 ||| NNS
aged  ||| S:1064 E:1069 ||| VBN
less  ||| S:1069 E:1074 ||| JJR
than  ||| S:1074 E:1079 ||| IN
1  ||| S:1079 E:1081 ||| CD
year ||| S:1081 E:1085 ||| NN
.  ||| S:1085 E:1087 ||| .
The  ||| S:1087 E:1091 ||| DT
transplant  ||| S:1091 E:1102 ||| NN
rate  ||| S:1102 E:1107 ||| NN
has  ||| S:1107 E:1111 ||| VBZ
increased  ||| S:1111 E:1121 ||| VBN
since  ||| S:1121 E:1127 ||| IN
2002 ||| S:1127 E:1131 ||| CD
,  ||| S:1131 E:1133 ||| ,
and  ||| S:1133 E:1137 ||| CC
is  ||| S:1137 E:1140 ||| VBZ
highest  ||| S:1140 E:1148 ||| JJS
in  ||| S:1148 E:1151 ||| IN
candidates  ||| S:1151 E:1162 ||| NNS
aged  ||| S:1162 E:1167 ||| VBN
less  ||| S:1167 E:1172 ||| JJR
than  ||| S:1172 E:1177 ||| IN
1  ||| S:1177 E:1179 ||| CD
year ||| S:1179 E:1183 ||| NN
.  ||| S:1183 E:1185 ||| .
Graft  ||| S:1185 E:1191 ||| JJ
survival  ||| S:1191 E:1200 ||| NN
continues  ||| S:1200 E:1210 ||| VBZ
to  ||| S:1210 E:1213 ||| TO
improve  ||| S:1213 E:1221 ||| VB
for  ||| S:1221 E:1225 ||| IN
pediatric  ||| S:1225 E:1235 ||| JJ
recipients  ||| S:1235 E:1246 ||| NNS
of  ||| S:1246 E:1249 ||| IN
deceased  ||| S:1249 E:1258 ||| JJ
donor  ||| S:1258 E:1264 ||| NN
and  ||| S:1264 E:1268 ||| CC
living  ||| S:1268 E:1275 ||| VBG
donor  ||| S:1275 E:1281 ||| NN
livers ||| S:1281 E:1287 ||| NN
.  ||| S:1287 E:1289 ||| .
Incidence  ||| S:1289 E:1299 ||| NN
of  ||| S:1299 E:1302 ||| IN
acute  ||| S:1302 E:1308 ||| JJ
rejections  ||| S:1308 E:1319 ||| JJ
increases  ||| S:1319 E:1329 ||| NNS
with  ||| S:1329 E:1334 ||| IN
time  ||| S:1334 E:1339 ||| NN
after  ||| S:1339 E:1345 ||| IN
transplant ||| S:1345 E:1355 ||| NN
.  ||| S:1355 E:1357 ||| .
Posttransplant  ||| S:1357 E:1372 ||| JJ
lymphoproliferative  ||| S:1372 E:1392 ||| JJ
disorder  ||| S:1392 E:1401 ||| NN
remains  ||| S:1401 E:1409 ||| VBZ
an  ||| S:1409 E:1412 ||| DT
important  ||| S:1412 E:1422 ||| JJ
concern  ||| S:1422 E:1430 ||| NN
in  ||| S:1430 E:1433 ||| IN
pediatric  ||| S:1433 E:1443 ||| JJ
recipients ||| S:1443 E:1453 ||| NNS
.  ||| S:1453 E:1455 ||| .
